<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="208488">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00373919</url>
  </required_header>
  <id_info>
    <org_study_id>erythro-esophagus</org_study_id>
    <nct_id>NCT00373919</nct_id>
  </id_info>
  <brief_title>The Effect of Erythromycin on Occurrence of Leaks From Cervical Esophageal-Gastric Anastomosis After Trans-Hiatal Esophagectomy</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kaplan Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kaplan Medical Center</source>
  <brief_summary>
    <textblock>
      Cervical anastomotic leak is one of the most common complications after trans-hiatal
      esophagectomy.

      Hypothesis: An early post operative administration of a pro-kinetic dosage of erythromycin
      will reduce leak occurrence.

      Design: This is a prospective, randomized, double blind, placebo controlled study.

      Number of patients: 30.

      Inclusion Criteria:

        -  Patients after trans-hiatal esophagectomy

      Exclusion Criteria:

        -  Allergy to erythromycin

        -  Use of phenothiazine

        -  QT prolongation

        -  Liver function test (LFT) abnormalities

        -  Myasthenia gravis

        -  Cardiomyopathy
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double-Blind</masking>
  </study_design_info>
  <condition>Esophagectomy</condition>
  <condition>Postoperative Complications</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>intravenous (IV) administration of erythromycin</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients after trans-hiatal esophagectomy

        Exclusion Criteria:

          -  Allergy to erythromycin

          -  Use of phenothiazine

          -  QT prolongation

          -  Liver function test (LFT) abnormalities

          -  Myasthenia gravis

          -  Cardiomyopathy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Koram Klein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kaplan Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yoram Klein, MD</last_name>
    <phone>972-50-8213221</phone>
    <email>yoramkl@clalit.org.il</email>
  </overall_contact>
  <verification_date>August 2006</verification_date>
  <lastchanged_date>March 2, 2007</lastchanged_date>
  <firstreceived_date>September 7, 2006</firstreceived_date>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Erythromycin</mesh_term>
    <mesh_term>Erythromycin Estolate</mesh_term>
    <mesh_term>Erythromycin Ethylsuccinate</mesh_term>
    <mesh_term>Erythromycin stearate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
